Tyra biosciences to participate at upcoming investor conferences

Carlsbad, calif. , may 12, 2025 /prnewswire/ -- tyra biosciences, inc. (nasdaq: tyra), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in fibroblast growth factor receptor (fgfr) biology, today announced that management will participate in the following investor conferences: bank of america global healthcare conference, may 13-15, 2025 format: fireside chat and one-on-one investor meetings presentation date/time: tuesday, may 13, 2025, at 5:15 pm pt location: las vegas, nv jefferies global healthcare conference, june 3-5, 2025 format: one-on-one investor meetings location: new york, ny ubs biotech 1x1 symposium, june 24, 2025 format: one-on-one investor meetings location: new york, ny a live and archived webcast of the fireside chat will be available via the for investors page on the investor section of the tyra website.
TYRA Ratings Summary
TYRA Quant Ranking